Insight Molecular Diagnostics Inc.
IMDX
$3.59+6.21%
End of day · as of Sep 30, 2026, 7:00 PM ET
Mkt cap
$117.12M
EV/Sales
26.0
P/E ratio
N/A
FY2025 Revenue
$4.05M
EPS (TTM)
$-1.52
Gross Margin (FY2025)
56.67%
Profit Margin (FY2025)
-1238.52%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Insight Molecular Diagnostics Inc. (IMDX) is a diagnostics & research company listed on US.
Latest reported IMDX revenue for 2025-12-31 was $4.1M. Net income was -$50.2M. Revenue was up 115.6% from 2024-12-31 to 2025-12-31. IMDX currently screens at market cap $117.1M.
Use this IMDX research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full IMDX income, balance, and cash tables.
Insight Molecular Diagnostics Inc. (IMDX) is a diagnostics & research company in the Healthcare sector.
Latest cached Insight Molecular Diagnostics Inc. (IMDX) revenue for Dec 31, 2025 was $4.1M. Net income was -$50.2M. Statements: https://lician.com/financials/imdx
Insight Molecular Diagnostics Inc. (IMDX) market capitalization is $117.1M on the latest cached snapshot.
Insight Molecular Diagnostics Inc. (IMDX) cached previous close $3.38; day range $3.31 – $3.67; volume 287,108. Session quote: https://lician.com/quote/imdx
Insight Molecular Diagnostics Inc. (IMDX) latest cached earnings event is "IMDX earnings" on Aug 10, 2026. Earnings calendar: https://lician.com/earnings
The latest cached IMDX filing is 8-K · Sep 21, 2026. Filings: https://lician.com/sec/imdx